CompletedNot Applicable

Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green.

Germany60 participants

Plain-language summary

It was the aim of the present study to prospectively compare the functional and morphological outcome of idiopathic epiretinal membrane surgery with and without the assistance of Indocyanine green (ICG). The main outcome measure was improvement of best-corrected visual acuity (BCVA). This was treated as an open question and we had no hypothesis which of the two therapies was superior.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with IEM and cataract or posterior chamber intraocular lens pseudophakia complaining of loss of visual acuity and metamorphopsia during the past six months. Exclusion Criteria: * Other retinal disease, non-idiopathic epiretinal membrane, glaucoma or history of retinal detachment.

What they're measuring

The main outcome measure was improvement of best-corrected visual acuity (BCVA).

Trial details

NCT IDNCT00376857

SponsorUniversity of Regensburg

Sponsor typeOTHER

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Idiopathic Epiretinal Membrane, Cataract trials